Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

The Pressure Is On For African Americans With Hypertension
Nearly two-thirds (63 percent) of African Americans with high blood pressure (also known as hypertension) say they worry more about their finances than their personal health, according to a new "My Pressure Points"(TM) national survey commissioned by Daiichi Sankyo, Inc., in collaboration with the Association of Black Cardiologists.(1) In addition, almost half (48 percent) are stressed about their work and careers. Everyone juggles many external pressures in everyday life like jobs, finances and family care. But while those African Americans surveyed have increased their focus on the external pressures, have they lost sight of a critical internal pressure - one that can impact every facet of their lives? The survey was designed to test this hypothesis.

Heart Patients Are Twice As Likely To Quit Smoking With Intensive In-Hospital Support
A new study in CMAJ (Canadian Medical Association Journal) shows that patients admitted to a hospital with coronary artery disease are twice as likely to quit smoking after receiving intensive smoking cessation support than those receiving minimal support.
News of the day
Vitamin D Repletion Does Not Alter Urinary Calcium Excretion In Healthy Postmenopausal Women
UroToday.com - Vitamin D needs, especially in the northern latitudes where direct sunlight is unavailable for much of the year, are currently under scrutiny by members of both the scientific and medical communities. Vitamin D primarily plays a role in regulating calcium absorption in the gastrointestinal tract. However, epidemiologic and laboratory studies support the notion that vitamin D might play a role in chemoprevention - particularly of cancers of the colon, breast, ovarian, and prostate (Garland et al., Am J Public Health 2006;96:252-61) - immune modulation and prevention of certain autoimmune disorders (Cantorna et al., Exp Biol Med 2004;229:1136-1142), promoting bone integrity and preserving muscle mass (Montero-Odasso et al., Mol Aspects Med 2005;26:203-19), cardiovascular disease prevention (Wang et al., Circulation 2008;117:503-11), and prevention of all-cause mortality (Melamed et al., Arch Intern Med 2008;168:1629-37).
Endocrinology

2009 Recipient Of Minority Scholar Award Begins Clinical Research On Leukemia

Alejandro Gutierrez, MD, is the third recipient of the ASH-AMFDP grant, an award designed to help increase the number of underrepresented minority scholars in the field of hematology, and will begin his research into the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) this month. The award, the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation, provides four years of support, including an annual stipend of up to $75,000 and an annual grant of more than $29,000 for research activities. "I am truly honored to have been selected as the 2009 recipient of the ASH-AMFDP," said Dr. Gutierrez. "This award represents an outstanding career development opportunity for which I am most grateful, and I look forward to years of productive collaboration with ASH and the AMFDP." His research is entitled "Unraveling the Molecular Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Using Zebrafish Genetics and Small Molecule Screens," and will focus on harnessing the strengths of the zebrafish model system to unravel the molecular pathogenesis of T-cell acute lymphoblastic leukemia. Specifically, Dr. Gutierrez is interested in identifying targetable molecular pathways that are required for the survival of MYC-overexpressing thymocytes using a zebrafish small molecule screen, and in uncovering the functional roles of novel T-ALL oncogenes and tumor suppressors in our zebrafish model of this disease. Dr. Gutierrez is currently Instructor in Pediatrics, Dana-Farber Cancer Institute, Children"s Hospital Boston, Harvard Medical School. For more information, please see the ASH-AMFDP page on the ASH Web site. The American Society of Hematology is the world"s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ASH launched Blood: The Vital Connection , a credible online re addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options. The American Society of Hematology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009